Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Neoplasm Proteins. Found 49 abstracts

no pagination
Qian L, Soderquist C, Schrank-Hacker A, Strauser H, Dupoux V, Tang CN, Smith JR, Sun A, Majumdar S, Nguyen T, Widura S, Landsburg DJ, Schuster SJ, Baxter RH, Bogusz AM. Deletion 20q12 is associated with histological transformation of nodal marginal zone lymphoma to diffuse large B-cell lymphoma. American journal of hematology. 2020 Mar;95(3):238-44.
Go CK, Gross S, Hooper R, Soboloff J. EGR-mediated control of STIM expression and function. Cell calcium. 2019 Jan;77:58-67.   PMCID: PMC6467086
Ghatalia P, Zibelman MR, Geynisman DM, Plimack ER. Evolving landscape of the treatment of metastatic clear cell renal cell carcinoma. Clinical advances in hematology & oncology : H&O. 2018 Oct;16(10):677-86.
Michael JV, Wurtzel JG, Mao GF, Rao AK, Kolpakov MA, Sabri A, Hoffman NE, Rajan S, Tomar D, Madesh M, Nieman MT, Yu J, Edelstein LC, Rowley JW, Weyrich AS, Goldfinger LE. Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth. Blood. 2017 Aug 03;130(5):567-80.   PMCID: PMC5542851
Troupes CD, Wallner M, Borghetti G, Zhang C, Mohsin S, von Lewinski D, Berretta RM, Kubo H, Chen X, Soboloff J, Houser S. Role of STIM1 (Stromal Interaction Molecule 1) in Hypertrophy-Related Contractile Dysfunction. Circulation research. 2017 Jul 07;121(2):125-36.   PMCID: PMC5531450
Dasgupta Y, Koptyra M, Hoser G, Kantekure K, Roy D, Gornicka B, Nieborowska-Skorska M, Bolton-Gillespie E, Cerny-Reiterer S, Muschen M, Valent P, Wasik MA, Richardson C, Hantschel O, van der Kuip H, Stoklosa T, Skorski T. Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases. Blood. 2016 Apr 28;127(17):2131-43.   PMCID: PMC4850868
Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal D, El-Naggar AK, Garden AS, Soulieres D, Trotti A, Avizonis VN, Ridge JA, Harris J, Le QT, Gillison M. Reply to B. O'Sullivan et Al. J Clin Oncol. 2015 May 20;33(15):1708-9.
Hochster HS, Uboha N, Messersmith W, Gold PJ, O Neil BH, Cohen D, Denlinger C, Cohen S, Leichman CG, Leichman L, Lenz HJ. Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer. Cancer Chemother Pharmacol. 2015 Jan;75(1):17-23.
Hooper R, Zhang X, Webster M, Go C, Kedra J, Marchbank K, Gill DL, Weeraratna AT, Trebak M, Soboloff J. Novel Protein Kinase C-Mediated Control of Orai1 Function in Invasive Melanoma. Mol Cell Biol. 2015 Aug;35(16):2790-8.   PMCID: 4508319
Barr PM, Miller TP, Friedberg JW, Peterson DR, Baran AM, Herr M, Spier CM, Cui H, Roe DJ, Persky DO, Casulo C, Littleton J, Schwartz M, Puvvada S, Landowski TH, Rimsza LM, Dorr RT, Fisher RI, Bernstein SH, Briehl MM. Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma. Blood. 2014 Aug 21;124(8):1259-65.   PMCID: Pmc4141515
Keller LM, Galloway TJ, Holdbrook T, Ruth K, Yang D, Dubyk C, Flieder D, Lango MN, Mehra R, Burtness B, Ridge JA. p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell carcinomas of unknown primary. Head & neck. 2014 Dec;36(12):1677-84.   PMCID: PMC3972378
Sodani K, Patel A, Anreddy N, Singh S, Yang DH, Kathawala RJ, Kumar P, Talele TT, Chen ZS. Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo. Biochemical pharmacology. 2014 May;89(1):52-61.   PMCID: Pmc3983711
Cheung M, Testa JR. Diverse mechanisms of AKT pathway activation in human malignancy. Curr Cancer Drug Targets. 2013 Mar;13(3):234-44.   PMCID: PMC3678724
Meyer JE, Panico VJ, Marconato HM, Sherr DL, Christos P, Pirog EC. HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer. J Gastrointest Cancer. 2013 Dec;44(4):450-5.   PMCID: Pmc3963822
Patel BB, Li XM, Dixon MP, Blagoi EL, Nicolas E, Seeholzer SH, Cheng D, He YA, Coudry RA, Howard SD, Riddle DM, Cooper HC, Boman BM, Conrad P, Crowell JA, Bellacosa A, Knudson A, Yeung AT, Kopelovich L. APC +/- alters colonic fibroblast proteome in FAP. Oncotarget. 2011 Mar;2(3):197-208.   PMCID: PMC3195363
Ding Y, Larson G, Rivas G, Lundberg C, Geller L, Ouyang C, Weitzel J, Archambeau J, Slater J, Daly MB, Benson AB, Kirkwood JM, O'Dwyer PJ, Sutphen R, Stewart JA, Johnson D, Nordborg M, Krontiris TG. Strong signature of natural selection within an FHIT intron implicated in prostate cancer risk. PLoS ONE. 2008 Jan;3(10):e3533.   PMCID: PMC2568805
Crispen PL, Uzzo RG, Golovine K, Makhov P, Pollack A, Horwitz EM, Greenberg RE, Kolenko VM. Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention. The Prostate. 2007 May;67(6):582-90.
Zhang R, Chen W, Adams PD. Molecular dissection of formation of senescence-associated heterochromatin foci. Mol Cell Biol. 2007 Mar;27(6):2343-58.
Hartman TR, Qian S, Bolinger C, Fernandez S, Schoenberg DR, Boris-Lawrie K. RNA helicase A is necessary for translation of selected messenger RNAs. Nature structural & molecular biology. 2006 May 07;13(6):509-16.
Zhang R, Poustovoitov MV, Ye X, Santos HA, Chen W, Daganzo SM, Erzberger JP, Serebriiskii IG, Canutescu AA, Dunbrack RL, Pehrson JR, Berger JM, Kaufman PD, Adams PD. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Developmental cell. 2005 Jan;8(1):19-30.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Neoplasm Proteins

Neoplasm Proteins metabolism genetics Male pathology Female Aged Middle Aged biosynthesis Adult Mice Neoplastic Gene Expression Regulation physiology drug therapy therapeutic use Antineoplastic Agents Mutation antagonists & inhibitors Case-Control Studies Oxidative Stress Neoplasm Invasiveness Tumor Cell Line Squamous Cell Carcinoma 80 and over Aged Biological Tumor Markers Molecular Sequence Data Proto-Oncogene Proteins Histones ras Proteins Cell Cycle Survival Analysis Protein Kinase Inhibitors Transcription Factors Papillomaviridae 0 (Neoplasm Proteins) Neoplasm Drug Resistance Drug Dose-Response Relationship Heterochromatin Stromal Interaction Molecule 1 Cell Aging Non-Histone Chromosomal Proteins drug effects Repressor Proteins Cell Line Gene Expression Regulation isolation & purification mortality Calcium Amino Acid Sequence Calcium Signaling Survival Rate adverse effects Papillomavirus Infections virology Cell Cycle Proteins me [Metabolism] Pyridazines Prostatic Neoplasms Neoplasm Metastasis administration & dosage analogs & MAP Kinase Kinase Kinases Cats 107283-02-3 (heterochromatin-specific nonhistone chromosomal Cohort Studies Down-Regulation 0 (Cell Cycle Proteins) B-Cell Lymphoma-Marginal Zone Colorectal Neoplasms Tyrosine kinase inhibitor Proteinase-Activated Receptors 0 (Transcription Factor AP-1) agonists 0 (Histones) Proto-Oncogene Proteins c-akt Phenotype derivatives NADH Dehydrogenase Apoptosis MicroRNAs pd [Pharmacology] Human Chromosomes-Pair 20 Introns Selection (Genetics) Biological) 0 (Tumor Markers 17407-37-3 (vitamin E succinate) HIV Seropositivity 0 (NF-kappa B) SCID Mice B-Cell Lymphoma Telatinib Lung Neoplasms Anus Neoplasms Acid Anhydride Hydrolases Clear Cell Adenocarcinoma Neoplastic Stem Cells Proto-Oncogene Proteins c-abl Nuclear Proteins Angiogenesis Inhibitors Experimental Leukemia Enzyme Activation Melanoma Cell-Derived Microparticles 0 (Nuclear Proteins) 0 (Repressor Proteins) Immunoenzyme Techniques Skin Neoplasms stim1 Protein Kinase C Vascular Endothelial Growth Factor A Age Factors Oropharyngeal Neoplasms Western Blotting Transcription Factor AP-1 Gene Expression Profiling calcium Camptothecin Vitamin E Intracellular Signaling Peptides and Proteins Fibroblasts Recombinant Fusion Proteins aa [Analogs & Derivatives] Molecular Models Cardiomegaly Non-US Gov't Research Support NF-kappa B Superoxide Dismutase Protein Biosynthesis Local Neoplasm Recurrence Dosage Compensation (Genetics) 0 (macroH2A histone) Conserved Sequence transplantation human papillomavirus (HPV) protein HP-1) use Immunohistochemistry ai [Antagonists & Inhibitors] Animal Disease Models Cell Adhesion Young Adult Nude Mice Follow-Up Studies Biological Models therapy DEAD-box RNA Helicases Imidazoles Viral DNA human) 0 (ASF1A protein Cultured Cells
Last updated on Friday, July 10, 2020